Cooley advised FibroGen on its $120 million shelf takedown of 5,228,750 shares of common stock. FibroGen, which is headquartered in San Francisco and trades on The…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now